NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a dividend yield of 3.80%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its board has initiated a share repurchase program on Tuesday, May 22nd 2018, which allows the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 3.1% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.

Metlife Inc (NYSE:MET) announced its earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to analysts' expectations of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. Metlife's revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.20 EPS. View Metlife's Earnings History.

17 Wall Street analysts have issued 1-year price targets for Metlife's stock. Their predictions range from $47.00 to $78.00. On average, they anticipate Metlife's stock price to reach $56.60 in the next year. This suggests a possible upside of 28.1% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a drop in short interest during the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a drop of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily trading volume, of 7,086,353 shares, the days-to-cover ratio is currently 1.7 days. Approximately 1.4% of the company's stock are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News articles about MET stock have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.06 on Accern's scale. They also gave headlines about the financial services provider an impact score of 45.47 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Metlife's stock is owned by a number of of retail and institutional investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Retirement Systems of Alabama (0.06%), Deprince Race & Zollo Inc. (0.05%) and Lodestar Investment Counsel LLC IL (0.04%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Deprince Race & Zollo Inc., Gateway Investment Advisers LLC, Cullinan Associates Inc. and Franklin Street Advisors Inc. NC. View Insider Buying and Selling for Metlife.

MET stock was bought by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Retirement Systems of Alabama, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc. and State of Alaska Department of Revenue. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.19.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.